Scavenger receptors in innate immunity

Current Opinion in Immunology

Volumn 8, Issue 1, 1996, Pages 20-28

  Pearson, Alan M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; SCAVENGER;

BLOOD CELL; HOST RESISTANCE; IMMUNE RESPONSE; LIGAND BINDING; MACROPHAGE; MONOCYTE; RECEPTOR GENE; REVIEW;

EID: 0029916999     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80100-2     Document Type: Article

References (92)

1. Gordon S, Perry VH, Rabinowitz S, Chung L-P, Rosen H: Plasma membrane receptors of the mononuclear phagocyte system. J Cell Sci Suppl 1988, 9:1-26.
2. Hoffmann JA: Innate immunity of insects. Curr Opin Immunol 1995, 7:4-10.
3. Hultmark D: Immune reactions in Drosophila and other insects: a model for innate immunity. Trends Genet 1993, 9:178-183.
4. Janeway CA: The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992, 13:11-16.
5. Janeway CA: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989 54:1-13.
6. Drickarner K, Taylor ME: Biology of animal lectins. Annu Rev Cell Biol 1993, 9:237-264.
7. Pugin J, Heumann D, Tomasz A, Kravchenko VV, Akamatsu R, Nishijima M, Glauser MP, Tobias PS, Ulevitch RJ: CD14 is a pattern recognition receptor. Immunity 1994, 1:509-516. CD14 is the first known cell-surface receptor that mediates the activation of macrophages in response to surface molecules from multiple classes of pathogenic microorganisms (Gram-positive and Gram-negative bacteria, mycobacteria).
8. Freeman M, Ashkenas J, Rees DJ, Kingsley DM, Copeland NG, Jenkins NA, Krieger M: An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci USA 1991, 88:4931-4935.
9. Krieger M, Herz J: Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994, 63:601-637. A comprehensive review of the SR-AI and SR-AII SRs, and of another multiligand-binding receptor, LRP.
10. Abrams JM, Lux A, Steller H, Krieger M: Macrophages in Drosophila embryos and L2 cells exhibit scavenger receptor-mediated endocytosis. Proc Natl Acad Sci USA 1992, 89:10375-10379.
11. Pearson A, Lux A, Krieger M: Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc Natl Acad Sci USA 1995, 92:4056-4060. This paper and [10] report the first demonstration of SR activity in any non-mammalian species, the cloning of a gene responsible for at least some of this activity, and the characterization of the protein product. The receptor exhibits broad binding specificity, including the ability to bind microbial molecules known to induce an immune response in Drosophila. These findings demonstrate that SR activities and pattern-recognition receptors are indeed evolutionarily ancient.
12. Acton SL, Scherer PE, Lodish HF, Krieger M: Expression cloning of SR-BI, a CD36-releted class B scavenger receptor. J Biol Chem 1994, 269:21005-21009. Describes the cloning and characterization of SR-BI, the second known class B SR.
13. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M: Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 1990, 343:531-535.
14. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M: Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 1990, 343:570-572.
15. Resnick D, Pearson A, Krieger M: The SRCR super-family: a family reminiscent of the Ig superfamily. Trends Biochem Sci 1994, 19:5-8.
16. Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA: The type I macrophage scavenger receptor binds to Gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci USA 1994, 91:1863-1867. Demonstrates that SR-AI can bind to a wide range of intact Gram-positive bacteria and to lipoteichoic acid, a surface constituent of these bacteria.
17. Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CRH: Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991, 352:342-344.
18. Naito M, Kodama T, Matsumoto A, Doi T, Takahashi K: Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors. Am J Pathol 1991, 139:1411-1423.
19. Hughes DA, Fraser IP, Gordon S: Muringe macrophage scavenger receptor: in vivo expression and function as a receptor for macrophage adhesion in lymphoid and non-lymphoid organs. Eur J Immunol 1995, 25:466-473. This paper describes the expression of SR-AI/II in most tissue macrophage populations, including macrophages of the lymph glands, thymus and spleen. It is also demonstrated that SR-AI/II can act as an adhesion receptor to mediate the binding of macrophages to frozen tissue sections from the lymph gland, thymus and spleen.
20. Geng Y-J, Hansson GK: High endothelial cells of postcapillary venules express the scavenger receptor in human peripheral lymph nodes. Scand J Immunol 1995, 42:289-296.
21. Li H, Freeman MW, Libby P: Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 1995, 95:122-133.
22. De Villiers WJS, Fraser IP, Hughes DA, Doyle AG, Gordon S: Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J Exp Med 1994, 180:705-709.
23. Geng Y, Kodama T, Hansson GK: Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb 1994, 14:798-806.
24. Horvai A, Palinski W, Wu H, Moulton KS, Kalla K, Glass CK: Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci USA 1995, 92:5391-5395.
25. 1. J Lipid Res 1995, 36:1305-1314.
26. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, Liakka A, Thesleff I, Kraal G, Tryggvason K: Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995, 80:603-609. This paper describes the cloning and characterization of MARCO, the newest class A SR. Interestingly, this protein binds bacteria and is expressed in a very restricted subset of tissue macrophages in the marginal zone of the spleen and the medullary cord of the lymph nodes.
27. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993, 268:11811-11816. Although not strictly within the period of review, this paper is important as it describes the identification and characterization of CD36 as the first non-class A macrophage scavenger receptor.
28. Vega MA, Segui-Real B, Garcia JA, Calés C, Rodriuez F, Vanderkerckhove J, Sandoval IV: Cloning, sequencing, and expression of a cDNA encoding rat LIMPII, a novel 74-kDA lysosomal membrane protein related to the surface adhesion protein CD36. J Biol Chem 1991, 266:16818-16824.
29. Hart K, Wilcox M: A Drosophila gene encoding an epithelial membrane protein with homology to CD36/LIMP II. J Mol Biol 1993, 234:249-253.
30. Greenwalt DE, Lipsky RH, Ochenhouse CF, Ikeda H, Tandon NN, Jamieson GA: Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992, 80:1105-1115.
31. Pearce SFA, Wu J, Silverstein RL: A carboxy terminal truncation mutant of CD36 is secreted and binds thrombospondin: evidence for a single transmembrane domain. Blood 1994, 84:384-389.
32. Armesilla AL, Vega MA: Structural organization of the gene for human CD36 glycoprotein. J Biol Chem 1994, 269:18985-18991.
33. König H, Pfisterer P, Corcoran LM, Wirth T: Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev 1995, 9:1598-1607.
34. Rigotti A, Acton SL, Krieger M: The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995, 270:16221-16224. This paper reports that SR-BI and CD36 recognize anionic phospholipid vesicles, including PS vesicles. These receptors are thus the first, and so far the only, molecularly well defined cell-surface receptors for anionic phospholipids to be described. This important development should contribute greatly to our understanding of SR-B ligand recognition and function in lipid metabolism, in host-defense-related processes and, in particular, in the recognition and engulfment of apoptotic cells.
35. Greenwalt DE, Scheck SH, Rhinehart-Jones T: Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest 1995, 96:1382-1388. This paper suggests, with supporting citations, that CD36 is an important lipid-binding protein involved in the metabolism of plasma fatty acids, and demonstrates a positive correlation between blood triglyceride levels and CD36 expression on capillary endothelial cells.
36. Nicholson AC, Frieda S, Pearce A, Silverstein RL: Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol 1995, 15:269-275.
37. Abumrad NA, El-Maghrabi MR, Amri E-Z, Lopez E, Grimalds PA: Cloning of a rat adipocyte membrane protein implicated in binding of transport of long-chain fatty acids that is induced during preadlpocyte differentiation; homology with human CD36. J Biol Chem 1993, 268:17665-17668.
38. Swerlick RA, Lee KH, Wick TM, Lawley TJ: Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992, 148:78-83.
39. Ratner S, Schroit AJ, Vinson SB, Fidler U: Analogous recognition of phospholipids by insect phagocytes and mammalian macrophages. Proc Soc Exp Biol Med 1986, 182:272-276.
40. Reid KBM, Day AJ: Structure-function relationships of the complement components. Immunol Today 1989, 6:177-180.
41. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314.
42. Li SH, Burns DK, Rumberger JM, Presky DH, Wilkinson VL, Anostario M, Wolitzky BA, Norton CR, Familletti PC, Kim KJ et al.: Consensus repeat domains of E-selectin enhance ligand binding. J Biol Chem 1994, 269:4431-4437.
43. Zondag GCM, Koningstein GM, Jiang Y-P, Sap J, Moolenaar WH, Gebbink MFBG: Homophilic interactions mediated by receptor tyrosine phosphatases μ and κ; a critical role for the novel extracellular MAM domain. J Biol Chem 1995, 270:15247-14250.
44. Holness CL, Da Silva RP, Fawcett J, Gordon S, Simmons DL: Macroslalin, a mouse macrophage-restrlcted glycoprotein, is a member of the lamp/lgp family. J Biol Chem 1993, 268:9661-9666.
45. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D: The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidyiserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 1995, 92:9580-9584.
46. Nishikawa K, Arai H, Inoue K: Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J Biol Chem 1990, 265:5226-5231.
47. Arai H, Kita T, Yokode M, Narumiya S, Kawai C: Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages; different uptake mechanisms for acetylated and oxidized low density lipoproteins. Biochem Biophys Res Commun 1989, 159:1375-1382.
48. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Kameda-Takemura K et al.: Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 1995, 96:1859-1865. This paper reports the first known functional difference between CD36-negative and CD36-positive macrophages.
49. Sambrano GR, Steinberg D: Recognition of oxidatively damaged and apoptotlc cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci USA 1995, 92:1396-1400. This paper, together with [89•], reports that a PS-binding SR expressed in peritoneal macrophages (elicited and resident) participates in the binding and/or uptake of oxidized red blood cells and apoptotic cells. These papers also provide evidence to suggest the participation of multiple receptors in these processes, which probably include multiple SRs.
50. Schnitzer JE, Bravo J: High affinity binding, endocytosis, and degradation of conformationally modified albumins; potential role of gp30 and gp18 as novel scavenger receptors. J Biol Chem 1993, 268:7562-7570.
51. Kuzmenko YS, Boxhkov VN, Philippova MP, Tkachuk VA, Resink TJ: Characterization of an atypical lipoprotein-binding protein in human aortic membranes by ligand blotting. Biochem J 1994, 303:281-287.
52. Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995, 13:437-457.
53. Wright SD: CD14 and innate recognition of bacteria. J Immunol 1995 155:6-8. A highly readable and very interesting commentary on potential mechanisms by which CD14, together with other proteins, may mediate cellular activation in response to LPS, Gram-negative bacteria, and infectious microorganisms more generally.
54. Ingalls RR, Golenbock DT: CD11C/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med 1995, 181:1473-1479. Reports the isolation of the first known CD14-independent signalling receptor for LPS.
55. Castro M, Ralston, NVC, Morgenthaler TI, Rohrbach MS, Limper AH: Candide albicans stimulates arachidonic acid liberation from alveolar macrophages through α-mannan and β-glucan cell wall components. Infect Immun 1994, 62:3138-3145.
56. Golenbock DT, Liu Y, Millham FH, Freeman MW, Zoeller RA: Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J Biol Chem 1993, 268:22055-22059.
57. Bell MD, Lopez-Gonzalez R, Lawson L, Hughes D, Fraser I, Gordon S, Perry VH: Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J Neurocytol 1994, 23:605-613.
58. Huh HY, Lo, SK, Yesner LM, Silverstein RL: CD36 induction on human monocytes upon adhesion to tumor necrosis factor-activated endothelial cells. J Biol Chem 1995, 270:6267-6271.
59. Kobzik L: Lung macrophage uptake of unopsonized environmental particulates; role of scavegner-type receptors. J Immunol 1995 155: 367-376.
60. Resnick D, Freedman N, Xu S, Krieger M: Secreted extracellular domains of macrophage scavenger receptors form elongated trimers which specifically bind crocidolite asbestos. J Biol Chem 1993, 268:3538-3545.
61. Abraham R, Singh N, Mukhopadhyay A, Basu SK, Bal V, Rath S: Modulation of immunogenicity and antigenicity of proteins by maleylatlon to target scavenger receptors on macrophages. J Immunol 1995, 154:1-8.
62. Hennet T, Ziltener HJ, Frei K, Peterhans E: A kinetic study of immune mediators in the lungs of mice infected with infulenza A virus. J Immunol 1992, 149:932-939.
63. Rizki TM, Rizki RM: The cellular defense system of Drosophila melanogaster. In Insect Ultrastructure, vol 2. Edited by King RC, Akai H. New York: Plenum; 1984:579-604.
64. Lackie AM: Haemocyte behavior. Adv Insect Physiol 1988, 21:85-178.
65. Machin SJ: The clotting system. In Encyclopedia of Immunology, vol 1. Edited by Roitt IM, Delves PJ. San Diego: Academic Press; 1992:359-363.
66. Davie EW, Fujikawa K, Kisiel W: The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991, 30:10363-10370.
67. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwège V, Hedman H, Freyssinet J-M: Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysoccharide. J Immunol 1994, 153:3245-3255.
68. Rutherford MS, Witsell A, Schook LB: Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J Leukoc Biol 1993, 53:602-618.
69. Fraser I, Hughes D, Gordon S: Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to muring scavenger receptor. Nature 1993, 364:343-346.
70. Zhou L, Hashimi H, Schwartz LM, Nambu JR: Programmed cell death in the Drosophila central nervous system midline. Curr Biol 1995 5: 784-790. The first report that Drosophila hemocytes appear to follow specific guidance cues during at least some of their migrations through the embryo.
71. Tepass U, Fessler LI, Aziz A, Hartenstein V: Embryonic origin of hemocytes and their relationship to cell death in Drosophila. Development 1994, 120:1829-1837. Describes the origin, migration and stage-specific distribution of the hemocytes in the developing embryo.
72. Harris BH, Gelfand JA: The immune response to trauma. Semin Pediatr Surg 1995, 4:77-82.
73. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994, 15:74-80.
74. Mansfield PJ, Suchard SJ: Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol 1994, 153:4219-4229.
75. Burnet FM: Evolution of the immune process in vertebrates. Nature 1968, 218:426-430.
76. Ibrahim MAA, Chain BM, Katz DR: The injured cell: the role of the dendritic cell system as a sentinel receptor pathway. Immunol Today 1995, 16:181-186. A recent and very interesting extension of Janeway's pattern-recognition hypothesis in which the authors propose that innate and adaptive immune responses are initiated not only by microbial surface constituents, but also by microenvironmental tissue injury, and that the macrophage-like dendritic cells are key mediators of the immune response to injury.
77. Silverstein FL, Asch AS, Nachman RL: Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest 1989, 84:546-552.
78. Saelman EUM, Kehrel KM, De Groot PG, Sixma JJ, Nieuwenhuis HK: Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV. Blood 1994, 83:3240-3244.
79. Savill J, Fadok V, Henson P, Haslett C: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993, 14:131-136.
80. Shresta S, MacIvor DM, Heusel JW, Russell JH, Ley TJ: Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci USA 1995, 92:5679-5683.
81. Munn DH, Beall AC, Song D, Wrenn RW, Throckmorton DC: Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon. J Exp Med 1995, 181:127-136.
82. Greenberg JT, Guo A, Klessig DF, Ausubel FM: Programmed cell death in plants: a pathogen-triggered response activated coordinately with multiple defense functions. Cell 1994, 77:551-563.
83. Steller H: Mechanisms and genes of cellular suicide. Science 1995, 267:1445-1449.
84. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994, 372:100-103.
85. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992, 148:2207-2216.
86. Savill J, Hogg N, Ren Y, Haslett C: Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992, 90:1513-1522.
87. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM: Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992, 149:4029-4035.
88. Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995, 181:1857-1862. A direct demonstration, by cDNA transfeclion studies, that CD36 participates in VnR/TSP-dependent apoptotic cell engulfment.
89. Ottnad E, Parthasarathy S, Sambrano GR, Ramprasad MP, Quehenberger O, Kondratenko N, Green S, Steinberg D: A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci USA 1995, 92:1391-1395. See annotation [49••].
90. Lee K-D, Pitas RE, Papahadjopoulos D: Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. Biochim Biophys Acts 1992, 1111:1-6.
91. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Kreiger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271:518-520. This paper reports that SR-BI binds HDL, provides the first demonstration that a CD36 family member can mediate the cellular accumulation of large amounts of lipoprotein-derived cholesterol and lipid, and shows that this process occurs via a mechanism different from the classic endosome/lysosome pathway. The paper also reports that SR-BI is expressed primarily by non-placental steroidogenic tissues and the liver, suggesting exciting possible functions for SR-BI in the mechansims of streoid biosynthesis and reverse cholesterol transport.
92. Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Arai H, Inoue K: SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res 1996, 222:246-250.